0001585808-18-000002.txt : 20180515
0001585808-18-000002.hdr.sgml : 20180515
20180515150830
ACCESSION NUMBER: 0001585808-18-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20180515
DATE AS OF CHANGE: 20180515
EFFECTIVENESS DATE: 20180515
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cotinga Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001585808
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 0430
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-312440
FILM NUMBER: 18835719
BUSINESS ADDRESS:
STREET 1: SUITE 230B, THE MOGENSON CENTRE
STREET 2: 100 COLLIP CIRCLE
CITY: LONDON
STATE: A6
ZIP: N6G 4X8
BUSINESS PHONE: 519-858-5157
MAIL ADDRESS:
STREET 1: SUITE 230B, THE MOGENSON CENTRE
STREET 2: 100 COLLIP CIRCLE
CITY: LONDON
STATE: A6
ZIP: N6G 4X8
FORMER COMPANY:
FORMER CONFORMED NAME: CRITICAL OUTCOME TECHNOLOGIES INC.
DATE OF NAME CHANGE: 20130904
D
1
primary_doc.xml
X0708
D
LIVE
0001585808
Cotinga Pharmaceuticals Inc.
SUITE 230B, THE MOGENSON CENTRE
100 COLLIP CIRCLE
LONDON
A6
ONTARIO, CANADA
N6G 4X8
519-858-5157
ONTARIO, CANADA
CRITICAL OUTCOME TECHNOLOGIES INC.
Corporation
true
ALISON
SILVA
700 COLLIP CIRCLE, SUITE 213
LONDON
A6
ONTARIO, CANADA
N6G 4X8
Executive Officer
Director
GENE
KELLY
700 COLLIP CIRCLE, SUITE 213
LONDON
A6
ONTARIO, CANADA
N6G 4X8
Executive Officer
JOHN
C
DRAKE
700 COLLIP CIRCLE, SUITE 213
LONDON
A6
ONTARIO, CANADA
N6G 4X8
Director
DOUGLAS
S
ALEXANDER
700 COLLIP CIRCLE, SUITE 213
LONDON
A6
ONTARIO, CANADA
N6G 4X8
Director
DAVID
SANDERSON
700 COLLIP CIRCLE, SUITE 213
LONDON
A6
ONTARIO, CANADA
N6G 4X8
Director
JOHN
YOO
700 COLLIP CIRCLE, SUITE 213
LONDON
A6
ONTARIO, CANADA
N6G 4X8
Director
Biotechnology
Decline to Disclose
- 06b
false
2018-05-03
false
true
true
true
false
0
Roth Capital Partners LLC
15407
None
None
888 Clemente Drive
Newport Beach
CA
CALIFORNIA
92660
NY
NEW YORK
false
1580439
1580439
0
false
6
167558
0
0
false
Cotinga Pharmaceuticals Inc.
/s/Alison Silva
Alison Silva
Chief Executive Officer
2018-05-15